Interleukin-17A Antagonist [EPC]

114946 reported adverse events

Drugs of this class: IXEKIZUMAB SECUKINUMAB

These side effects are most commonly reported by patients taking drugs of the Interleukin-17A Antagonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 17940
1 PSORIASIS 15523
2 PAIN 8099
3 ARTHRALGIA 7316
4 MALAISE 5232
5 PRURITUS 4893
6 FATIGUE 4481
7 DIARRHOEA 4151
8 INJECTION SITE PAIN 4080
9 PSORIATIC ARTHROPATHY 3985
See all common reactions for Interleukin-17A Antagonist [EPC]

Drugs of the Interleukin-17A Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PSORIASIS AREA SEVERITY INDEX INCREASED 29 0.4603
1 TONSILLAR ULCER 41 0.3475
2 REBOUND PSORIASIS 75 0.3333
3 MACULE 548 0.2916
4 DACTYLITIS 144 0.2722
5 RED BLOOD CELL SEDIMENTATION RATE 45 0.2711
6 NAIL PSORIASIS 86 0.2696
7 ENTHESOPATHY 237 0.2568
8 SERONEGATIVE ARTHRITIS 117 0.2505
9 SKIN PLAQUE 1127 0.2144
See all enriched reactions for Interleukin-17A Antagonist [EPC]